RecruitingNot ApplicableNCT07425756

taVNS Combined With TENS on Motor Function in Stroke

Effect of Combining Transcutaneous Vagus Nerve Stimulation With Peripheral Nerve Stimulation on Upper Limb Motor Function in People With Stroke: A Single- Blinded Randomised Controlled Trial


Sponsor

The Hong Kong Polytechnic University

Enrollment

120 participants

Start Date

Jan 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

the current study is a Blinded Randomised Controlled Trial investing the effectiveness of Combining Transcutaneous Vagus Nerve Stimulation with Peripheral Nerve Stimulation on Upper Limb Motor Function in People with Stroke


Eligibility

Min Age: 50 YearsMax Age: 75 Years

Inclusion Criteria5

  • aged 55 - 75 years old;
  • diagnosed with stroke confirmed by magnetic resonance imaging or computed tomography for more than 6 months;
  • had volitional control of the non-paretic arm and at least minimal antigravity movement in the paretic shoulder;
  • had at least 5 degrees of wrist extension in the antigravity position;
  • be able to communicate

Exclusion Criteria3

  • had neurological disease other than stroke, e.g., Parkinson's disease or dementia;
  • ongoing healthy condition, e.g., angina pectoris, pain, or arthritis;
  • had any contraindications of taVNS (metal implants in the brain, history of seizure)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEtranscutaneous auricular vagus nerve stimulation

The left cymba conchae was selected as taVNS stimulation side. The taVNS was delivered by earphone-shaped stimulators for 30 minutes with the stimulation parameters as follows: 0.3-ms square pulses at 20 Hz for 30 seconds with a duty cycle of 1:1; and the intensity of the stimulation was individually adjusted according to the tolerance of participants

DEVICEsham transcutaneous auricular vagus nerve stimulation

The sham stimulation will be delivered with a shame model of the same device that used in the taVNS intervention. The interference of the device will display that the device is working normally while no electrical current output.

DEVICEtranscutaneous electrical nerve stimulation

TENS will be delivered with commercial TENS machine. The stimulation parameters were as follows: continuous 0.2-ms square pulses at 100 Hz with the intensity adjusted according to the tolerance of each patient. Disposable surface electrodes of 5X5 cm2 were applied to stimulate the median nerve and the superficial radial nerve of both the affected and non-affected upper limbs. The placebo stimulation was delivered with a device that looked identical but had its internal electrical circuit disconnected.

DEVICEsham transcutaneous electrical nerve stimulation

The sham stimulation will be administered using a device that looks identical to the TENS device used in the TENS intervention. However, the internal electrical circuit of this device will be disconnected.

OTHERtask-oriented training

A physiotherapist supervised the intervention and monitored individual progress. The task-oriented training aims to improve the motor recovery of the upper limbs through the systematic and repetitive movement of shoulder, elbow, forearm, wrist and fingers. The task-oriented training will be conducted in seating position with a table in front. Each training task will be repeated for 10 repetitions per set with 1 minute of rest between sets.The progressions are repositioning from gravity eliminate to against position, improve movement quality, increasing number of sets and shortening rest period.


Locations(1)

The Hong Kong Polytechnic University

Kowloon, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07425756


Related Trials